Total Payments
$2,379
2024 Payments
$1,181
Companies
19
Transactions
75
Medicare Patients
9,003
Medicare Billing
$631,311
Payment Breakdown by Category
Food & Beverage$1,234 (51.9%)
Travel$1,145 (48.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,234 | 73 | 51.9% |
| Travel and Lodging | $1,145 | 2 | 48.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $1,181 | 3 | $0 (2024) |
| Mallinckrodt LLC | $290.01 | 16 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $167.34 | 11 | $0 (2020) |
| Relypsa, Inc. | $129.02 | 7 | $0 (2019) |
| Genentech USA, Inc. | $126.12 | 9 | $0 (2019) |
| Amgen Inc. | $95.60 | 5 | $0 (2018) |
| OPKO Pharmaceuticals, LLC | $74.23 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $67.26 | 3 | $0 (2021) |
| Keryx Biopharmaceuticals, Inc. | $40.11 | 3 | $0 (2018) |
| Shire North American Group Inc | $30.59 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,181 | 3 | CSL Behring ($1,181) |
| 2023 | $38.22 | 2 | ANI Pharmaceuticals, Inc. ($19.33) |
| 2021 | $63.18 | 3 | Mallinckrodt Hospital Products Inc. ($29.54) |
| 2020 | $37.28 | 2 | AstraZeneca Pharmaceuticals LP ($22.76) |
| 2019 | $225.95 | 14 | Otsuka America Pharmaceutical, Inc. ($76.38) |
| 2018 | $483.40 | 30 | Mallinckrodt LLC ($121.59) |
| 2017 | $350.28 | 21 | Mallinckrodt LLC ($168.42) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $259.30 | General |
| 10/17/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $35.75 | General |
| 10/16/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $886.00 | General |
| 06/22/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/17/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 06/23/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Immunology | ||||||
| 04/12/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEPHROLOGY | ||||||
| 10/18/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Hyperkalemia | ||||||
| 10/16/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: BioOncology/Immunology | ||||||
| 08/01/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEPHROLOGY | ||||||
| 07/16/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEPHROLOGY | ||||||
| 06/18/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Hyperparathyroidism | ||||||
| 06/18/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEPHROLOGY | ||||||
| 05/21/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEPHROLOGY | ||||||
| 03/12/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: NEPHROLOGY | ||||||
| 03/12/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.56 | General |
| Category: NEPHROLOGY | ||||||
| 02/08/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/06/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Hyperkalemia | ||||||
| 01/14/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Immunology | ||||||
| 12/06/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 38 | 4,416 | 7,540 | $984,987 | $279,653 |
| 2020 | 37 | 4,587 | 12,541 | $1.4M | $351,657 |
Total Patients
9,003
Total Services
20,081
Medicare Billing
$631,311
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 62 | 383 | $312,505 | $103,293 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 326 | 428 | $130,082 | $39,105 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 190 | 430 | $89,255 | $22,785 | 25.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 104 | 295 | $61,923 | $16,324 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 110 | $63,891 | $16,128 | 25.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2021 | 258 | 381 | $64,271 | $15,625 | 24.3% |
| 82306 | Vitamin d-3 level | Office | 2021 | 257 | 352 | $42,588 | $10,370 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 106 | $31,705 | $8,407 | 26.5% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 18 | 760 | $28,112 | $4,955 | 17.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 20 | $13,705 | $4,623 | 33.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 251 | 375 | $13,208 | $3,924 | 29.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 328 | 483 | $15,345 | $3,727 | 24.3% |
| 90947 | Dialysis procedure requiring repeat evaluation | Facility | 2021 | 12 | 39 | $14,018 | $3,714 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 24 | $9,839 | $3,239 | 32.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 159 | 159 | $8,099 | $2,806 | 34.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 318 | 463 | $9,792 | $2,381 | 24.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 20 | 45 | $7,425 | $2,058 | 27.7% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 23 | 49 | $7,350 | $1,881 | 25.6% |
| 84156 | Total protein level, urine | Office | 2021 | 329 | 483 | $7,245 | $1,760 | 24.3% |
| 84100 | Phosphate level | Office | 2021 | 245 | 363 | $6,490 | $1,709 | 26.3% |
| 80069 | Kidney function blood test panel | Office | 2021 | 141 | 156 | $4,399 | $1,354 | 30.8% |
| 84550 | Uric acid level, blood | Office | 2021 | 202 | 302 | $5,581 | $1,354 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 311 | 438 | $3,942 | $1,307 | 33.2% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 48 | 72 | $4,011 | $970.19 | 24.2% |
| G0420 | Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | Office | 2021 | 11 | 11 | $3,466 | $900.69 | 26.0% |
About Dr. Claude Galphin, MD
Dr. Claude Galphin, MD is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700883816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Claude Galphin, MD has received a total of $2,379 in payments from pharmaceutical and medical device companies, with $1,181 received in 2024. These payments were reported across 75 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,234).
As a Medicare-enrolled provider, Galphin has provided services to 9,003 Medicare beneficiaries, totaling 20,081 services with total Medicare billing of $631,311. Data is available for 2 years (2020–2021), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 07/05/2005
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1700883816
Products in Payments
- ACTHAR (Biological) $319.55
- Veltassa (Drug) $129.02
- Rituxan (Biological) $126.12
- SAMSCA (Drug) $122.44
- Parsabiv (Biological) $95.60
- Rayaldee (Drug) $74.23
- LOKELMA (Drug) $47.43
- JYNARQUE (Drug) $44.90
- Auryxia (Drug) $40.11
- Uloric (Drug) $27.92
- ENTRESTO (Drug) $23.33
- PURIFIED CORTROPHIN GEL (Drug) $19.33
- AURYXIA (Drug) $18.90
- BENLYSTA (Biological) $18.89
- NATPARA (PARATHYROID HORMONE) (Drug) $16.29
- SOLIRIS (Drug) $14.89
- NATPARA (Drug) $14.30
- Ultomiris (Drug) $13.81
- KRYSTEXXA (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449